156 related articles for article (PubMed ID: 16696074)
1. c-erbB3 protein expression in ovarian cancer.
Rajkumar T; Stamp GW; Hughes CM; Gullick WJ
Clin Mol Pathol; 1996 Aug; 49(4):M199-202. PubMed ID: 16696074
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of C-erbb3 expression in squamous-cell carcinomas of the cervix as determined by the monoclonal-antibody rtj2.
Rajkumar T; Majhi U; Malligarjuna V; Gullick W
Int J Oncol; 1995 Jan; 6(1):105-9. PubMed ID: 21556509
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-erbB3 protein in primary breast carcinomas.
Naidu R; Yadav M; Nair S; Kutty MK
Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
[TBL] [Abstract][Full Text] [Related]
4. [Overexpression of C-erbB3 in transitional cell carcinoma of the ovary].
Shen K; Lang J; Guo L
Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):658-61. PubMed ID: 8745489
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery.
Lee JC; Wang ST; Chow NH; Yang HB
Eur J Cancer; 2002 May; 38(8):1065-71. PubMed ID: 12008194
[TBL] [Abstract][Full Text] [Related]
6. c-erbB-3 protein expression in ovarian tumours.
Simpson BJ; Weatherill J; Miller EP; Lessells AM; Langdon SP; Miller WR
Br J Cancer; 1995 Apr; 71(4):758-62. PubMed ID: 7710941
[TBL] [Abstract][Full Text] [Related]
7. [Relationship of expression of C-erbB2, C-erbB3, and C-erbB4 with ovarian carcinoma].
Li L; Zhong YP; Zhang W; Zhang JQ; Yao ZQ
Ai Zheng; 2004 May; 23(5):568-72. PubMed ID: 15142456
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues.
Lee H; Maihle NJ
Oncogene; 1998 Jun; 16(25):3243-52. PubMed ID: 9681822
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
Schmandt RE; Broaddus R; Lu KH; Shvartsman H; Thornton A; Malpica A; Sun C; Bodurka DC; Gershenson DM
Cancer; 2003 Aug; 98(4):758-64. PubMed ID: 12910520
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage-independent growth of breast cancer cell lines.
Rajkumar T; Gullick WJ
Br J Cancer; 1994 Sep; 70(3):459-65. PubMed ID: 8080731
[TBL] [Abstract][Full Text] [Related]
12. ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.
Jardé T; Kass L; Staples M; Lescesen H; Carne P; Oliva K; McMurrick PJ; Abud HE
PLoS One; 2015; 10(9):e0138336. PubMed ID: 26367378
[TBL] [Abstract][Full Text] [Related]
13. [Overexpression of c-erbB-2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients].
Meden H; Marx D; Rath W; Kuhn W; Hinney B; Schauer A
Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):667-73. PubMed ID: 1360438
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of the type 1 growth factor receptor family in the conjunctival epithelium of patients with keratoconjunctivitis sicca.
Liu Z; Carvajal M; Carothers Carraway CA; Carraway KL; Pflugfelder SC
Am J Ophthalmol; 2000 Apr; 129(4):472-80. PubMed ID: 10764856
[TBL] [Abstract][Full Text] [Related]
15. Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.
Young CD; Nolte EC; Lewis A; Serkova NJ; Anderson SM
Breast Cancer Res; 2008; 10(4):R70. PubMed ID: 18700973
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical perspective of PPAR beta and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours.
Ahmed N; Riley C; Quinn MA
Br J Cancer; 2008 Apr; 98(8):1415-24. PubMed ID: 18349831
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.
Denkert C; Weichert W; Pest S; Koch I; Licht D; Köbel M; Reles A; Sehouli J; Dietel M; Hauptmann S
Cancer Res; 2004 Jan; 64(1):189-95. PubMed ID: 14729623
[TBL] [Abstract][Full Text] [Related]
18. Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1.
Rajkumar T; Gooden CS; Lemoine NR; Gullick WJ; Goden CS
J Pathol; 1993 Jul; 170(3):271-8. PubMed ID: 8133400
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.
Berchuck A; Rodriguez GC; Kamel A; Dodge RK; Soper JT; Clarke-Pearson DL; Bast RC
Am J Obstet Gynecol; 1991 Feb; 164(2):669-74. PubMed ID: 1992720
[TBL] [Abstract][Full Text] [Related]
20. TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas.
Skomedal H; Kristensen GB; Abeler VM; Børresen-Dale AL; Tropé C; Holm R
J Pathol; 1997 Feb; 181(2):158-65. PubMed ID: 9120719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
